Skye Bioscience

Developer of cannabinoid-based therapies for the treatment of glaucoma and other diseases

placeSan Diego, California, United States calendar_todayFounded 2011 groups11 employees language skyebioscience.com

Registered entities

Social engagement

Social engagement: 3.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Hilco Vision.

Investor typeCountShare
Venture capital450%
Private equity113%
Other / undisclosed338%

Recent activity

7 Apr 2026
Event
GLP-1-Based Therapeutics Summit
10 Mar 2026
Event
Skye Bioscience webcast
10 Mar 2026
Milestone
revenue
Coming soon